ProfileGDS4718 / 1565738_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 30% 32% 29% 35% 33% 31% 31% 34% 36% 39% 36% 35% 29% 33% 30% 29% 36% 33% 33% 35% 36% 34% 38% 35% 36% 36% 37% 46% 34% 37% 32% 31% 32% 34% 30% 35% 32% 34% 37% 32% 40% 35% 30% 34% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.5424730
GSM549102patient 115, normal, homogenized [OPG study]4.6567932
GSM549104patient 119, normal, homogenized [OPG study]4.4752429
GSM549108patient 138, normal, homogenized [OPG study]4.8102835
GSM549119patient 077, normal, homogenized [OPG study]4.6798933
GSM549133patient 032, cancer, homogenized [OPG study]4.5256231
GSM549139patient 042, cancer, homogenized [OPG study]4.5620831
GSM549099patient 107, normal, homogenized [OPG study]4.7571234
GSM549109patient 139, normal, homogenized [OPG study]4.8376136
GSM549110patient 046, normal, homogenized [OPG study]4.9507839
GSM549114patient 063, normal, homogenized [OPG study]4.7805636
GSM549122patient 082, normal, homogenized [OPG study]4.7794435
GSM549134patient 033, cancer, homogenized [OPG study]4.4970829
GSM549136patient 036, cancer, homogenized [OPG study]4.5990633
GSM549140patient 044, cancer, homogenized [OPG study]4.5094830
GSM549111patient 047, normal, homogenized [OPG study]4.4699629
GSM549113patient 057, normal, homogenized [OPG study]4.7664436
GSM549132patient 031, cancer, homogenized [OPG study]4.6468333
GSM549137patient 038, cancer, homogenized [OPG study]4.6685433
GSM549142patient 047, cancer, homogenized [OPG study]4.8597835
GSM549100patient 110, normal, homogenized [OPG study]4.8340936
GSM549107patient 135, normal, homogenized [OPG study]4.6832434
GSM549115patient 068, normal, homogenized [OPG study]4.8230438
GSM549116patient 072, normal, homogenized [OPG study]4.7299235
GSM549120patient 078, normal, homogenized [OPG study]4.8107536
GSM549131patient 030, cancer, homogenized [OPG study]4.729236
GSM549118patient 074, normal, homogenized [OPG study]4.8404437
GSM549129patient 027, cancer, homogenized [OPG study]5.346
GSM549123patient 088, normal, homogenized [OPG study]4.7126634
GSM549124patient 006, cancer, homogenized [OPG study]4.9092437
GSM549126patient 015, cancer, homogenized [OPG study]4.6060732
GSM549128patient 025, cancer, homogenized [OPG study]4.5708831
GSM549103patient 117, normal, homogenized [OPG study]4.693832
GSM549117patient 073, normal, homogenized [OPG study]4.7095334
GSM549138patient 041, cancer, homogenized [OPG study]4.530130
GSM549141patient 045, cancer, homogenized [OPG study]4.7078635
GSM549130patient 028, cancer, homogenized [OPG study]4.6278432
GSM549101patient 111, normal, homogenized [OPG study]4.7581634
GSM549105patient 128, normal, homogenized [OPG study]4.8690437
GSM549106patient 134, normal, homogenized [OPG study]4.6018632
GSM549112patient 048, normal, homogenized [OPG study]4.9853440
GSM549125patient 011, cancer, homogenized [OPG study]4.7737635
GSM549127patient 024, cancer, homogenized [OPG study]4.5400230
GSM549135patient 035, cancer, homogenized [OPG study]4.6451734